Clinical Trial

Surviving Pneumonia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2021 (before its estimated December 31, 2023 completion). Its status may not reflect the trial's current state.
Summary
The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-01-03; most recent amendment 2021-04-28.
Status change: Not Yet Recruiting → Recruiting 2019-09-05
Trial Details
NCT Number NCT03795662
Lead Sponsor Nordsjaellands Hospital
Conditions Community-acquired Pneumonia
Enrollment 2,500 participants
Start Date 2019-01-07
Primary Completion 2023-12-31 (estimated)
Study Completion 2038-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-04-29